| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6158866 | The Journal of Urology | 2016 | 20 Pages |
Abstract
Rates of the first report of sexual function related and other adverse experiences associated with doxazosin, finasteride and combination therapy were greatest during year 1 of treatment. These patterns should be considered by patients and physicians when treatment for lower urinary tract function is initiated with these drugs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Steven A. Kaplan, Jeannette Y. Lee, Alan G. Meehan, John W. Kusek,